سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Evaluation of Levofloxacin-containing Regime in Comparison with Clarithromycin-containing Regime in Eradicating Helicobacter pylori Infection in Kerman

Publish Year: 1401
Type: Journal paper
Language: English
View: 256

This Paper With 11 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_JKMU-29-2_002

Index date: 9 January 2023

Evaluation of Levofloxacin-containing Regime in Comparison with Clarithromycin-containing Regime in Eradicating Helicobacter pylori Infection in Kerman abstract

Background: Helicobacter pylori (H.pylori) is the main known cause of gastritis, gastroduodenal ulcer disease, and gastric cancer. Eradication of H.pylori can be an effective method of treatment for peptic ulcer disease and mucosa‐associated lymphoid tissue lymphoma. This study aimed to compare the effectiveness of levofloxacin versus clarithromycin in the eradication of H.pylori.Methods: This randomized clinical trial was conducted on 170 cases with H.pylori infection in Kerman. The participants were randomly allocated to two groups. As the first line therapy, ‘A’ group was treated twice a day with clarithromycin (500mg), pantoprazole (40mg) and amoxicillin (1gr) for 14 days and ‘B’ group was treated twice a day with levofloxacin (250mg), pantoprazole (40mg) and amoxicillin (1gr) for 14 days. Stool H.pylori antigen test was performed one month after the end of treatment. To analyze the data, descriptive and analytical methods and SPSS software version 22 were used.Results: The study cases were comprised of 170 individuals (52.35%female). The mean age of patients in ‘A’ and ‘B’ groups was 42±11.88 and 41±13.75 years, respectively. H.pylori eradication was successful in 61.1% of ‘A’ group and 92.9% of ‘B’ group showing a significant difference (P=0.037). Drug complications were reported in 7.1% of ‘A’ group and 4.7% of ‘B’ group which showed no significant difference between the two groups (P=0.772). The most common drug complication in both groups was abdominal pain (2.3%).Conclusion: The results of this study indicated that levofloxacin-containing regimen was more effective in eradicating H.pylori than the standard clarithromycin triple therapy.

Evaluation of Levofloxacin-containing Regime in Comparison with Clarithromycin-containing Regime in Eradicating Helicobacter pylori Infection in Kerman Keywords:

Evaluation of Levofloxacin-containing Regime in Comparison with Clarithromycin-containing Regime in Eradicating Helicobacter pylori Infection in Kerman authors

Bizhan Ahmadi

Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Masoud Hajmohammadi

Department of Internal Medicine, School of Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran

Ali Saeed pour

Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Motahareh Zaherara

Department of Medical Basic Sciences, School of Medicine, Bam University of Medical Sciences, Bam, Iran

Sara Shafieepour

۱. Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

Hoshang Ghazizadeh Ahsaei

Sepehr Laboratory, Kerman, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical ...
Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein ...
McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J ...
NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH ...
Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, ...
Hsu PI, Lai KH, Hsu PN, Lo GH, Yu HC, ...
Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy ...
Ables AZ, Simon I, Melton ER. Update on Helicobacter pylori ...
Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, ...
Morgner A, Bayerdörffer E, Neubauer A, Stolte M. Malignant tumors ...
Adamek RJ, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and ...
Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, ...
Mégraud F. H pylori antibiotic resistance: prevalence, importance, and advances ...
Collins J, Ali-Ibrahim A, Smoot DT. Antibiotic therapy for Helicobacter ...
Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection ...
Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, ...
Chung JW, Lee GH, Han JH, Jeong JY, Choi KS, ...
Gisbert JP, Calvet X. Review article: The effectiveness of standard ...
Graham DY, Fischbach L. Helicobacter pylori treatment in the era ...
Graham DY. Antibiotic resistance in Helicobacter pylori: Implications for therapy. ...
Vakil N, Vaira D. Non-invasive tests for the diagnosis of ...
De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi ...
Lee H, Hong SN, Min BH, Lee JH, Rhee PL, ...
Hung IF, Chan P, Leung S, Chan FS, Hsu A, ...
Saad RJ, Schoenfeld P, Kim HM, Chey WD. Levofloxacin-based triple ...
Gopal R, Elamurugan TP, Kate V, Jagdish S, Basu D. ...
Goudarzi M, Heidary M, Azad M, Fazeli M, Goudarzi H. ...
Haji-Aghamohammadi AA, Bastani A, Miroliaee A, Oveisi S, Safarnezhad S. ...
Khademi F, Poursina F, Hosseini E, Akbari M, Safaei HG. ...
Gisbert JP, Calvet X. Update on non-bismuth quadruple (concomitant) therapy ...
Treiber G, Wittig J, Ammon S, Walker S, van Doorn ...
Okada M, Oki K, Shirotani T, Seo M, Okabe N, ...
Kongchayanun C, Mahachai V, Pornthisarn B, Amornsawadwattana S, Vilaichone RK. ...
Moradniani M, Mirbeik-Sabzevari Z, Jaferian S, Shafiezadeh S, Ehsani Ardakani ...
Fakheri H, Bari Z, Taghvaei T, Hosseini V, Maleki I, ...
Tirgar Fakheri S, Sadough A, Fakheri H. Comparing Clarithromycin- and ...
Tariq H, Patel H, Kamal MU, Abbas N, Ameen M, ...
نمایش کامل مراجع